iGSK 945237
Alternative Names: 945237; GSK945237Latest Information Update: 02 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Class Antibacterials
- Mechanism of Action Ribosomal protein inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 13 May 2011 Discontinued - Phase-I for Bacterial infections in Australia (PO)